Abstract
School classrooms are enclosed settings where students and teachers spend prolonged periods of time and therefore risky environments for airborne transmission of SARS-CoV2. While countries worldwide have been pursuing different school reopening strategies, most EU countries are planning to keep schools open during the whole winter season 2020/21. Open schools in winter in highly epidemic areas pose a controversial issue: ventilation of classrooms (an essential mitigation factor for airborne transmission) is expected to sensibly decrease due to outdoor temperatures getting colder. More specifically, personnel and students will comprehensibly request window closure to maintain thermal comfort and regulators are going to allow less restrictive policies on windows closure. Fundamental questions therefore arise which urge to be addressed: to which extent can we contain airborne risk in schools during the cold season while reducing air ventilation? What would be the best mitigation strategy considering also the risk for other seasonal diseases and the fact that most schools are not provided with mechanical ventilation systems? To try answering these questions the theoretical link between intervals of ventilation (natural or mechanical) and the lowering of aerosol contagion risk is explored based on a mathematical model. A safety risk-zone and a theoretical optimum are presented which are based solely on face mask wearing and optimization of air change intervals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors founded this research work by themselves. no external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
this study is a pure theoretical analysis based on theroetical models of airborne transmission. It does not require IRB and/or ethics committee approvals
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
all data are available running numerical python code which solve the equations presented in paper.
